Study of MEN1112 Intravenous Infusion in Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT02353143 · TERMINATED

Trial details

NCT number: NCT02353143
Sponsor: Menarini Group
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Adult Acute Myeloid Leukemia Acute Myeloid Leukemia, in Relapse

Start date: 2014-12-01
Primary completion: 2021-04-09
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.